Vagus Nerve Stimulation For Heart Failure Fails To Impress, But BioControl Not Bothered
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific and Cyberonics report disappointing data on vagus nerve stimulation to treat heart failure at the European Society of Cardiology conference in Barcelona. But another developer of a VNS system for heart failure, BioControl, says the results won’t affect its chances for approval.